Learn How to Overcome Common Biometrics Obstacles Using a Cloud Based Statistical Computing Environment.
Join the journey with us by visiting one of our bi-weekly industry Blogs
Advance™ technology-enabled solution enables R&D organizations to cut study timelines, deliver cost savings and reduce animal experimentation.
Healthcare investment specialist ARCHIMED has the expertise, experience, enthusiasm and financial strength to fully back Instem’s ambitions.
New Software Module Introduced to Support the Latest Regulatory-approved Carcinogenic Potency Categorization Approach (CPCA)
To help you better evaluate our software or services, we believe an initial, no pressure Web session is the way to go.
We are excited that you have decided to take the next step with Instem. To provide you with an accurate quotation, we ask that you fill out our form.
© 2023 Instem Group of Companies